Literature DB >> 30486580

[Expert consensus on the application of next-generation sequencing in hematological neoplasms (2018)].

.   

Abstract

Entities:  

Year:  2018        PMID： 30486580     DOI： 10.3760/cma.j.issn.0253-2727.2018.11.001

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  5 in total

1.  [Distribution and prognostic value of LymphGen genotyping in patients with diffuse large B-cell lymphoma].

Authors:  F Zhang; Abulaiti Renaguli; X L Qi; Z Kou; S S Zhai; W Tan; Abuduer Muhebaier; Y L Nie; Y Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-04-14

2.  [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].

Authors:  Y Z Zheng; H Zheng; Z S Chen; X L Hua; S H Le; J Li; J D Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-01-14

3.  [The prognostic value of cloned genetic mutations in patients with CBFβ-MYH11 fusion-positive acute myeloid leukemia receiving intensive consolidation therapy].

Authors:  J Wang; S L Xue; Z Li; J Q Yu; C Wang; X L Chu; R Han; T Tao; T M Wu; B R Wang; C L Wan; Q C Qiu; X B Bao; D P Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-10-14

4.  [Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)].

Authors: 
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-09-20

5.  [Expert consensus on laboratory standardized technical specifications for monitoring minimal residual disease using next-generation sequencing in multiple myeloma(2021)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.